Regeneron Pharma earnings beat by $2.39, revenue fell short of estimates

This post was originally published on this site

Regeneron Pharma’s stock price closed at $751.20. It is up 0% in the last 3 months and up 20.59% in the last 12 months.

Regeneron Pharma saw 6 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See Regeneron Pharma’s stock price’s past reactions to earnings here.

According to InvestingPro, Regeneron Pharma’s Financial Health score is “great performance“.

Check out Regeneron Pharma’s recent earnings performance, and Regeneron Pharma’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar